These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 16393775)
1. Clinical significance of anti-citrullinated peptide antibody in Japanese patients with established rheumatoid arthritis. Nakamura H; Kawakami A; Ida H; Origuchi T; Matsuoka N; Tsuboi M; Furuyama M; Mizokami A; Tsukada T; Nakashima M; Ejima E; Hamasaki K; Aoyagi K; Uetani M; Fukuda T; Honda S; Urayama S; Kawabe Y; Ueki Y; Mine M; Eguchi K Scand J Rheumatol; 2005; 34(6):489-90. PubMed ID: 16393775 [No Abstract] [Full Text] [Related]
2. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis. van der Linden MP; van der Woude D; Ioan-Facsinay A; Levarht EW; Stoeken-Rijsbergen G; Huizinga TW; Toes RE; van der Helm-van Mil AH Arthritis Rheum; 2009 Aug; 60(8):2232-41. PubMed ID: 19644872 [TBL] [Abstract][Full Text] [Related]
3. Diagnostic utility of anti-cyclic citrullinated peptide antibodies for very early rheumatoid arthritis. Matsui T; Shimada K; Ozawa N; Hayakawa H; Hagiwara F; Nakayama H; Sugii S; Ozawa Y; Tohma S J Rheumatol; 2006 Dec; 33(12):2390-7. PubMed ID: 16924694 [TBL] [Abstract][Full Text] [Related]
4. Rheumatoid factor and anti-CCP autoantibodies in rheumatoid arthritis: a review. Lee AN; Beck CE; Hall M Clin Lab Sci; 2008; 21(1):15-8. PubMed ID: 18335856 [TBL] [Abstract][Full Text] [Related]
5. Likelihood ratios as a function of antibody concentration for anti-cyclic citrullinated peptide antibodies and rheumatoid factor. Bossuyt X; Coenen D; Fieuws S; Verschueren P; Westhovens R; Blanckaert N Ann Rheum Dis; 2009 Feb; 68(2):287-9. PubMed ID: 19139208 [No Abstract] [Full Text] [Related]
6. Clinical value of second- and third-generation assays of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis. Kitahara K; Takagi K; Kusunoki Y; Nishio S; Nozaki T; Inomata H; Takei M; Sawada S; Kawai S Ann Rheum Dis; 2008 Jul; 67(7):1059-60. PubMed ID: 18556455 [No Abstract] [Full Text] [Related]
7. Anti-cyclic citrullinated peptide in preclinical rheumatoid arthritis. Food for thought. Ménard HA J Rheumatol; 2009 Apr; 36(4):663-4. PubMed ID: 19342718 [No Abstract] [Full Text] [Related]
8. Diagnostic value of anticyclic citrullinated peptide antibody in rheumatoid arthritis. Jansen TL; Bruyn GA J Rheumatol; 2004 May; 31(5):1012-3; author reply 1013. PubMed ID: 15124273 [No Abstract] [Full Text] [Related]
9. Diagnostic value of anti-cyclic citrullinated peptide antibodies to detect rheumatoid arthritis in patients with Sjögren's syndrome. van Noord C; Hooijkaas H; Dufour-van den Goorbergh BC; van Hagen PM; van Daele PL; van de Merwe JP Ann Rheum Dis; 2005 Jan; 64(1):160-2. PubMed ID: 15608321 [No Abstract] [Full Text] [Related]
10. The role of anti-cyclic citrullinated peptide antibodies in predicting progression of palindromic rheumatism to rheumatoid arthritis. Russell AS; Devani A; Maksymowych WP J Rheumatol; 2006 Jul; 33(7):1240-2. PubMed ID: 16724377 [TBL] [Abstract][Full Text] [Related]
11. Can we rely on anti-citrulline antibody determination for the diagnosis of early rheumatoid arthritis? Bell DA J Rheumatol; 2006 Dec; 33(12):2369-71. PubMed ID: 17143974 [No Abstract] [Full Text] [Related]
12. [Anti-cyclic citrullinated peptide antibody as a serological marker for the diagnosis of rheumatoid arthritis]. Suzuki K Nihon Rinsho; 2005 Jan; 63 Suppl 1():341-3. PubMed ID: 15799374 [No Abstract] [Full Text] [Related]
13. [Anti-CCP antibody test: diagnostic and pronostic values in rheumatoid arthritis]. Tant L; Steinfeld S Rev Med Brux; 2006; 27(2):95-8. PubMed ID: 16736847 [TBL] [Abstract][Full Text] [Related]
14. Duration of pre-rheumatoid arthritis anti-cyclic citrullinated peptide positivity is positively associated with age at seroconversion. Bos WH; Nielen MM; Dijkmans BA; van Schaardenburg D Ann Rheum Dis; 2008 Nov; 67(11):1642. PubMed ID: 18854513 [No Abstract] [Full Text] [Related]
15. [Comparison and relevance of rheumatoid factors, antikeratin antibodies and anti-cyclic citrullinated peptides antibodies in rheumatoid arthritis]. Galati S; Beauvillain C; Renier G; Jeannin P; Masson C; Chevailler A Ann Biol Clin (Paris); 2008; 66(2):157-64. PubMed ID: 18390426 [TBL] [Abstract][Full Text] [Related]
16. Multiple antibody reactivities to citrullinated antigens in sera from patients with rheumatoid arthritis: association with HLA-DRB1 alleles. Snir O; Widhe M; von Spee C; Lindberg J; Padyukov L; Lundberg K; Engström A; Venables PJ; Lundeberg J; Holmdahl R; Klareskog L; Malmström V Ann Rheum Dis; 2009 May; 68(5):736-43. PubMed ID: 18635594 [TBL] [Abstract][Full Text] [Related]
17. Clinical evaluation of anti-mutated citrullinated vimentin by ELISA in rheumatoid arthritis. Soós L; Szekanecz Z; Szabó Z; Fekete A; Zeher M; Horváth IF; Dankó K; Kapitány A; Végvári A; Sipka S; Szegedi G; Lakos G J Rheumatol; 2007 Aug; 34(8):1658-63. PubMed ID: 17611988 [TBL] [Abstract][Full Text] [Related]
18. Diagnostic value of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis. Mofidi M; Moghadam A Saudi Med J; 2008 Aug; 29(8):1206-7. PubMed ID: 18690324 [No Abstract] [Full Text] [Related]
19. Do all anti-citrullinated protein/peptide antibody tests measure the same? Evaluation of discrepancy between anti-citrullinated protein/peptide antibody tests in patients with and without rheumatoid arthritis. Vander Cruyssen B; Nogueira L; Van Praet J; Deforce D; Elewaut D; Serre G; De Keyser F Ann Rheum Dis; 2008 Apr; 67(4):542-6. PubMed ID: 17644546 [TBL] [Abstract][Full Text] [Related]
20. Role of anticyclic citrullinated peptide in the diagnosis of early rheumatoid factor-negative suspected rheumatoid arthritis: is it worthwhile to order the test? Panchagnula R; Rajiv SR; Prakash J; Chandrashekara S; Suresh KP J Clin Rheumatol; 2006 Aug; 12(4):172-5. PubMed ID: 16891919 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]